Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Andrology, Vol. 26, No. 3, May/June 2005
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.04100

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jarow, J. P.
Right arrow Articles by Zirkin, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jarow, J. P.
Right arrow Articles by Zirkin, B. R.

Bioactivity of Androgens Within the Testes and Serum of Normal Men

JONATHAN P. JAROW*,{dagger}, WILLIAM W. WRIGHT{dagger}, TERRY R. BROWN{dagger}, XIAOHUA YAN*,{dagger} AND BARRY R. ZIRKIN{dagger}

From the * Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland; and the {dagger} Division of Reproductive Biology, Department of Biochemistry and Molecular Biology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland.

Correspondence to: Dr Jonathan P. Jarow, Department of Clinical Chemistry, University of Helsinki, 601 North Caroline St, Baltimore, MD 21287 (e-mail: jjarow{at}jhmi.edu).


Little is known about how human spermatogenesis is regulated, so it is not surprising that there have been few breakthroughs in the treatment of male infertility resulting from abnormalities of spermatogenesis. Testosterone is the predominant intratesticular steroid in both the rat and man. Previous studies have shown that the testosterone concentration within the rat testis that is required for the quantitative maintenance of spermatogenesis is far higher than the total testosterone concentration in rat blood, indicating that much of the testosterone within the testis might be biologically inactive. In contrast to the rat, little is known about the androgen requirements for human spermatogenesis, in part because, until recently, a minimally invasive method suitable for obtaining intratesticular fluids from the human testis has not been available. Percutaneous aspiration now makes it feasible to do so. A major objective of the present study was to assay the bioactive androgen concentration within the testes of normal, fertile men. Percutaneous aspiration was used to obtain intratesticular fluid from such men, and we adapted a highly sensitive recombinant protein mammalian cell-based bioassay to measure androgen bioactivity. Total intratesticular testosterone concentration, which we define as immunoreactive testosterone as measured by radioimmunoassay, was well in excess of that in serum (1236 ± 86 nM vs 11.7 ± 0.7 nM). The concentration of bioactive androgens within the normal human testis was found to be about two thirds that of the total testosterone concentration. Interestingly, the concentration of the major, known binding proteins for testosterone within the testis, serum hormone-binding globulin (SHBG)/ABP (52.4 ± 9.7 nM), was insufficient to account for the difference between total testosterone and bioactive androgens. This indicates that, in addition to its binding to SHBG/ABP, androgens may also be bound by unknown molecules, and that this contributes to reducing androgen bioactivity. These observations could have relevance for understanding the relationship between spermatogenesis and intratesticular androgens in normal men and in men diagnosed with infertility.

     Key words: Intratesticular testosterone, infertility, human




This article has been cited by other articles:


Home page
Cancer Res.Home page
G. Bagchi, J. Wu, J. French, J. Kim, N. H. Moniri, and Y. Daaka
Androgens Transduce the G{alpha}s-Mediated Activation of Protein Kinase A in Prostate Cells
Cancer Res., May 1, 2008; 68(9): 3225 - 3231.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. Boger-Megiddo, N. S. Weiss, M. J. Barnett, G. E. Goodman, and C. Chen
V89L Polymorphism of the 5{alpha}-Reductase Type II Gene (SRD5A2), Endogenous Sex Hormones, and Prostate Cancer Risk
Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 286 - 291.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. P. JAROW and B. R. ZIRKIN
The Androgen Microenvironment of the Human Testis and Hormonal Control of Spermatogenesis
Ann. N.Y. Acad. Sci., December 1, 2005; 1061(1): 208 - 220.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The American Society of Andrology.